Protein Science Sheba protein
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print September 25, 2006, 10.1110/ps.062283006
Protein Science (2006), 15:2656-2668. Published by Cold Spring Harbor Laboratory Press. Copyright © 2006 The Protein Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.062283006v1
15/11/2656    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quadt-Akabayov, S. R.
Right arrow Articles by Anglister, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quadt-Akabayov, S. R.
Right arrow Articles by Anglister, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Determination of the human type I interferon receptor binding site on human interferon-{alpha}2 by cross saturation and an NMR-based model of the complex

Sabine R. Quadt-Akabayov, Jordan H. Chill, Rina Levy, Naama Kessler, and Jacob Anglister

Department of Structural Biology, Weizmann Institute of Science, 76100 Rehovot, Israel

(RECEIVED April 11, 2006; FINAL REVISION August 7, 2006; ACCEPTED August 12, 2006)

Type I interferons (IFNs) are a family of homologous helical cytokines that exhibit pleiotropic effects on a wide variety of cell types, including antiviral activity and antibacterial, antiprozoal, immunomodulatory, and cell growth regulatory functions. Consequently, IFNs are the human proteins most widely used in the treatment of several kinds of cancer, hepatitis C, and multiple sclerosis. All type I IFNs bind to a cell surface receptor consisting of two subunits, IFNAR1 and IFNAR2, associating upon binding of interferon. The structure of the extracellular domain of IFNAR2 (R2-EC) was solved recently. Here we study the complex and the binding interface of IFN{alpha}2 with R2-EC using multidimensional NMR techniques. NMR shows that IFN{alpha}2 does not undergo significant structural changes upon binding to its receptor, suggesting a lock-and-key mechanism for binding. Cross saturation experiments were used to determine the receptor binding site upon IFN{alpha}2. The NMR data and previously published mutagenesis data were used to derive a docking model of the complex with an RMSD of 1 Å, and its well-defined orientation between IFN{alpha}2 and R2-EC and the structural quality greatly improve upon previously suggested models. The relative ligand–receptor orientation is believed to be important for interferon signaling and possibly one of the parameters that distinguish the different IFN I subtypes. This structural information provides important insight into interferon signaling processes and may allow improvement in the development of therapeutically used IFNs and IFN-like molecules.

Keywords: interferons; protein–protein docking; protein–protein interactions; multidimensional NMR; cross saturation



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Cironi, I. A. Swinburne, and P. A. Silver
Enhancement of Cell Type Specificity by Quantitative Modulation of a Chimeric Ligand
J. Biol. Chem., March 28, 2008; 283(13): 8469 - 8476.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. A. Langer
Interferon at 50: New Molecules, New Potential, New (and Old) Questions
Sci. Signal., September 25, 2007; 2007(405): pe53 - pe53.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Protein Society.